# Evaluation of Spectra Optia Red Blood Cell Exchange in Sickle Cell Patients

> **NCT01736657** · NA · COMPLETED · sponsor: **Terumo BCT** · enrollment: 73 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DEVICE:** Red blood cell exchange in sickle cell

## Key facts

- **NCT ID:** NCT01736657
- **Lead sponsor:** Terumo BCT
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2014-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01736657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01736657, "Evaluation of Spectra Optia Red Blood Cell Exchange in Sickle Cell Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01736657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*